Ganesh A. Thakur

The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Kelly S. Sink, Peter McLaughlin, Jodi Wood et al. · Neuropsychopharmacology · 2007 · 155 citations · Full text

Cannabis Use, Induce Signs, Psychoactive Drug +10

Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence

Richard A. Slivicki, Zhili Xu, Pushkar M. Kulkarni et al. · Biological Psychiatry · 2017 · 136 citations · Full text

Inflammation, Molecular Pharmacology, Pain Research +14

Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats

Elizabeth J. Rahn, A. M. Zvonok, Ganesh A. Thakur et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 113 citations · Full text

Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor

Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps et al. · ACS Chemical Neuroscience · 2017 · 106 citations

Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance

Jiayi Pan, Lívia P. Mendes, Momei Yao et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2019 · 101 citations

Nanomedicine, Nanotherapeutics, Engineering +12